Evaluating nsMRA Evidence in CKD and Type 1 Diabetes

Name: FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Uploaded: 2026-10-02T04:00:00+00:00
Duration: 1 min 30 s
Description: In this Data Pulse video brief, Dr. Katherine Tuttle examines FINE-ONE data on the efficacy and safety of finerenone according to age in patients with chro

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
Nephrology
INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
Peter Rossing, MD, DMSc
- Peter Rossing, MD, DMSc
Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
Heart Matters
Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
M. Melih Dogan, MD
- M. Melih Dogan, MD
Understanding Residual Cardiovascular Risk in CKD and T2D
Understanding Residual Cardiovascular Risk in CKD and T2D
Diabetes Discourse
Understanding Residual Cardiovascular Risk in CKD and T2D
John W. Ostrominski, MD, MPH
- John W. Ostrominski, MD, MPH
Is It Familial or Multifactorial Chylomicronemia Syndrome?
Is It Familial or Multifactorial Chylomicronemia Syndrome?
On the Frontlines of Familial Chylomicronemia Syndrome
Is It Familial or Multifactorial Chylomicronemia Syndrome?
Steve Jackson, PharmD; Michael D. Shapiro
- Steve Jackson, PharmD
- Michael D. Shapiro

FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes

Recommended

Title

Welcome to Global Cardiology Academy

Welcome to Global
Cardiology Academy